LHCSX Mutual Fund

LHCSX Mutual Fund

NAV$25.28
See how much of LHCSX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 50 of 57 holdings · as of Aug 31, 2026
LHCSX holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
LLY
Eli Lilly & CoHealth Care · Pharmaceuticals
10.27%		10.3%775$896.5KHealth CarePharmaceuticals
2
JNJ
Johnson & Johnson -Health Care · Pharmaceuticals
5.04%		15.3%1,656$440.2KHealth CarePharmaceuticals
Share changes, sector and industry · Pro
3
UNH
Unitedhealth Group Inc
4.97%		20.3%1,115$434.2K
4
NVS
Novartis Ag Ordinary Shares
4.00%		24.3%2,292$349.5K
5
GILD
Gilead Sciences
3.89%		28.2%2,323$339.9K
6
NTRA
Natera Inc
3.64%		31.8%988$318.1K
7
CVS
Cvs Health Corp
2.94%		34.8%2,734$256.8K
8
VRTX
Vertex Pharmaceuticals Inc
2.94%		37.7%471$256.5K
9
TXG
10x Genomics Inc Com Usd 1 Cl A
2.80%		40.5%3,910$244.2K
10
GH
Guardant Health, Inc
2.52%		43.0%1,381$219.6K
11—Thermo Fisher
2.44%		45.4%345$212.9K
12
GALD
Galderma
2.43%		47.9%1,023$212.5K
13—Beone Medicines Ltd
2.24%		50.1%7,131$196.0K
14
MDGL
Madrigal Pharmaceuticals Inc
2.16%		52.3%350$189.0K
15
ASND
Ascendis Pharma A/S
2.10%		54.4%698$183.6K
16—Argenx Se Common Stock EUR
2.05%		56.4%176$179.0K
17
COGT
Cogent Biosciences Inc
2.00%		58.4%4,983$174.4K
18
EW
Edwards Lifesciences Corp
1.84%		60.3%1,775$161.1K
19
RVMD
Revolution Medicines Inc
1.80%		62.1%764$157.1K
20
BBIO
Bridgebio Pharma Inc
1.73%		63.8%1,969$150.8K
21
ADPT
Adaptive Biotechnologies
1.54%		65.3%5,407$134.7K
22
PTGX
Protagonist Therapeutics Inc
1.53%		66.9%905$133.7K
23—Roche Holding Ag- Genusschein
1.51%		68.4%303$132.2K
24
ARWR
Arrowhead Pharmaceuticals Inc
1.45%		69.8%1,538$126.7K
25
ILMN
Illumina, Inc.
1.45%		71.3%594$126.9K
26
DNTH
Dianthus Therapeutics Inc
1.39%		72.7%1,152$121.7K
27
GKOS
Glaukos Corp.
1.38%		74.1%671$120.5K
28
MRK
Merck & Company Inc
1.37%		75.4%809$119.5K
29
UTHR
United Therapeutics Corp
1.37%		76.8%234$119.4K
30
PTCT
Ptc Therapeutics Inc
1.30%		78.1%1,632$113.5K
31—Otsuka Holdings
1.27%		79.4%1,448$111.0K
32—Roivant Sciences Ltd. Common Shares
1.25%		80.6%3,142$108.8K
33—Teva Pharmaceutical Industries Limited (Adr)
1.22%		81.8%2,957$106.6K
34
MIRM
Mirum Pharmaceuticals, Inc.
1.22%		83.1%1,087$106.6K
35
HNGE
Hinge Health Inc Ordinary Shares - Class A
1.19%		84.2%1,123$103.9K
36
ISRG
Intuitive Surgical Inc
1.12%		85.4%259$97.6K
37
CGON
Cg Oncology Inc
1.05%		86.4%1,223$91.9K
38
ELVN
Enliven Therapeutics Inc
0.98%		87.4%1,478$85.6K
39—Emcompass Health Corp
0.93%		88.3%677$81.4K
40
HTFL
Heartflow, Inc.
0.92%		89.2%1,602$80.7K
41
ORKA
Oruka Therapeutics Inc Orka
0.88%		90.1%828$76.7K
42
WST
West Pharmaceutical Services Inc
0.80%		90.9%204$69.6K
43
SOBIV
Swedish Orphan Biovitrum AB (publ) Shs
0.77%		91.7%1,428$67.1K
44
PRAX
Praxis Precision Medicines Inc
0.77%		92.5%193$67.6K
45—Ucb Sa
0.74%		93.2%260$65.0K
46
SYK
Stryker Corp
0.69%		93.9%186$60.2K
47
SDZ
Sandoz Group Ag
0.68%		94.6%704$59.2K
48—Definium Therapeutics, Inc. Common Shares
0.66%		95.2%1,459$58.0K
49—Suzhou Good-Ark Electronics Co Ltd
0.65%		95.9%51$56.6K
50
VEEV
Veeva Systems Inc
0.57%		96.5%174$49.7K
More holdings · Pro
FundXLS Pro
See the other 7 holdings of LHCSX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

LHCSX Mutual Fund All Holdings

LHCSX holdings total 57 positions. The top 10 holdings account for 43.0% of the fund, led by Eli Lilly & Co at 10.3%, Johnson & Johnson - Common at 5.0%, Unitedhealth Group Incorporated at 5.0%.

LHCSX portfolio concentration is moderate, with the top 10 representing 43.0% of total assets. The largest sector exposure is Health Care at 82.9%.

LHCSX sectors provide a detailed breakdown. LHCSX overlap shows how holdings compare to other funds in your portfolio.